U.D.S.

Search





All news

News

15 June 2015

CNRS innovation medals 2015

The video of Sylviane Muller and her team (Immunobiology and therapy of Lupus) can be viewed on the CNRS video library website
a movie from Marie Mora Chevais, produced by CNRS Images

Read more

28 April 2015

The artificial skin project discussed on Alsace 20, in the show "l’Alsace innovante et créative" (in french)

The artificial skin project highlighted in "l’Alsace innovante et créative", a show broadcasted by Alsace 20.
See below the interview of Vincent Flacher, CNRS researcher in the team "Immune-microenvironment interactions in health and disease" !
Watch the video

Read more

27 February 2015

World Lupus Day Strasbourg 2015

On 10 and 11 may 2015, the CNRS laboratory "Immunopathologie et Chimie Thérapeutique" and the Faculty of Medicine (University of Strasbourg) organize the first french symposium exclusively dedicated to the Lupus.
On this special occasion, eminent and internationally recognized personalities from the field will intervene. Patients’ associations will have a special space reserved for them on Monday from 12:45 to 14:45. The symposium is also open to patients !
The symposium is free of (...)

Read more

9 February 2015

Landmark collaboration agreement and commencement of Immupharma pivotal phase III LupuzorTM study with Simbec-Orion

ImmuPharma and the CRO Simbec-Orion Group have entered into a collaboration to run a Phase III clinical study of the potential lupus treatment Lupuzor.
Luzuzor (also known as Rigerimod, IPP-201101 and P140) is ImmuPharma’s lead compound for the treatment of Lupus, a chronic, potentially life-threatening autoimmune disease. Lupuzor has been granted fast track status by the US FDA and approved to start Phase III trials under a Special Protocol Assessment (SPA) due to its strong safety and (...)

Read more

8 April 2010

ImmuPharma awarded Best Drug Development Company in Europe Award 2010.

ImmuPharma PLC (LSE: IMM) the specialist discovery and development pharmaceutical company, has been voted "Best Drug Development Company, Europe" at The New Economy Pharmaceutical & Healthcare Awards 2010. This award follows on from two notable wins in 2009 namely; "Best Technology Award" at the AIM Awards, organized by the London Stock Exchange and "Breakthrough of the year 2009" at the European Mediscience (...)

Read more

A noter

 A noter

Adresse:
Immunologie, Immunopathologie et Chimie Thérapeutique
I.B.M.C.
15 Rue R. Descartes
67 084 Strasbourg
France
Directrice de l'UPR 3572
Hélène Dumortier
h.dumotier@ibmc-cnrs.unistra.fr
Secrétaire:
Isabelle Clauss
Tel: +33 (0)3 88 41 70 19
Fax: +33 (0)3 88 61 06 80
i.clauss@ibmc-cnrs.unistra.fr
Gestionnaire:
Christian Meier
Tel: +33 (0)3 88 41 70 10
Fax: +33 (0)3 88 61 06 80
c.meier@ibmc-cnrs.unistra.fr







   Labex Medalis
Plan d'Accès